Concordance of Abundance for Mutational <i>EGFR</i> and Co-Mutational <i>TP53</i> with Efficacy of <i>EGFR</i>-TKI Treatment in Metastatic Patients with Non-Small-Cell Lung Cancer
The present study aimed to investigate the influence of the mutation abundance of the epidermal growth factor receptor (<i>EGFR</i>) and its co-mutation with <i>TP53</i> on the therapeutic efficacy of tyrosine kinase inhibitor (TKI) treatment in patients with metastatic lung...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/30/9/616 |